OmniAb (OABI) Depreciation and Depletion (2022 - 2026)
OmniAb (OABI) reported Depreciation and Depletion of $606000.0 for Q1 2026, down 39.4% year-over-year from $1.0 million in Q1 2025, and down 84.46% on a QoQ basis from $3.9 million in Q4 2025.
OmniAb (OABI) has 5 years of Depreciation and Depletion data on file, last reported at $606000.0 in Q1 2026.
- Quarterly Depreciation and Depletion fell 39.4% year-over-year to $606000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (up 51.37% YoY) and the FY2025 annual result came in at $6.6 million, up 60.98% from the prior year.
- Depreciation and Depletion slipped to $606000.0 in Q1 2026 per OABI's latest filing, from $3.9 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $3.9 million in Q4 2025 and bottomed at $600000.0 in Q1 2022.
- The 5-year median for Depreciation and Depletion is $1.0 million (2023), against an average of $1.1 million.
- The widest annual swing landed in 2025, when Depreciation and Depletion surged 290.0%; it then slumped 39.4% in 2026.
- Tracing OABI's Depreciation and Depletion over 5 years: stood at $1.3 million in 2022, then dropped by 23.08% to $1.0 million in 2023, then retreated by 0.0% to $1000000.0 in 2024, then surged by 290.0% to $3.9 million in 2025, then sank by 84.46% to $606000.0 in 2026.
- Per Business Quant, the three latest OABI Depreciation and Depletion figures stand at $606000.0 (Q1 2026), $3.9 million (Q4 2025), and $900000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 606,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 606,000.00 |
| Mar 31, 2026 | 606,000.00 |
| Dec 31, 2025 | 3.90 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1,000,000.00 |
| Dec 31, 2024 | 1,000,000.00 |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 700,000.00 |
| Sep 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Mar 31, 2022 | 600,000.00 |
| Mar 31, 2022 | 600,000.00 |